|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
() | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 41,990 | 2716.231% | 6,160 | 6,930 |
| Cost of Sales | (265) | -41.242% | (1,140) | (149) |
| Gross Profit | 41,725 | 3912.019% | 5,020 | 6,781 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | (12,435) | -- | (5,566) | -- | |
| Share of Results of Asso. & JCEs | (114) | -52.500% | (609) | (915) | |
| Profit / (Loss) before Taxation | (183,096) | 9.434% | (364,456) | (160,396) | |
| Taxation | 0 | -- | 23 | 1 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (183,096) | 9.449% | (364,433) | (160,395) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (925) | -- | (90) | (4,241) |
| Depreciation & Amortisation | 16,994 | 8.063% | 32,136 | 22,434 |
| Directors' Emoluments | 36,839 | -20.829% | 101,861 | 4,068 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | |
| EPS (cts) | -318.000 | -0.935% | -681.000 | -317.000 |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (4.105) | (2.771) |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 04/12/2025 07:49 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -183,096 |
| %Change | 9.449% |
| EPS / (LPS) | RMB -3.180 |
| NBV Per Share (¥) | RMB -- |